Issue |
BIO Web Conf.
Volume 174, 2025
2025 7th International Conference on Biotechnology and Biomedicine (ICBB 2025)
|
|
---|---|---|
Article Number | 02026 | |
Number of page(s) | 6 | |
Section | Innovations in Therapeutics and Disease Mechanisms | |
DOI | https://doi.org/10.1051/bioconf/202517402026 | |
Published online | 12 May 2025 |
Statistical Modeling of Migraine Symptom Reduction in Middle-Aged and Elderly Patients: A Comparative Analysis of Aromatherapy Combined with Head Scraping Using Mean and SD Metrics
1 Wenshan Zhuang and Miao Autonomous Prefecture Hospital of Traditional Chinese Medicine, Wenshan, 663099, China
2 School of Food Science and Engineering, Guiyang University, Guiyang, 510005, China
a 2848125293@qq.com, b huangrenshuai@126.com c 522789104@qq.com
* Corresponding author: 1519622930@qq.com
Migraine, a prevalent chronic neurovascular disorder, exhibits high incidence rates among middle-aged and elderly populations, with prolonged reliance on conventional Western analgesics often exacerbating comorbidities such as anxiety and depression. To address this challenge, we propose a novel integrative approach combining traditional Chinese medicine (TCM) techniques—aromatherapy and head scraping—with modern statistical modeling to quantify therapeutic efficacy. Through a randomized controlled trial at Wenshan Prefecture Hospital of Traditional Chinese Medicine (with informed consent), migraine patients were stratified into four groups: control (CK), aromatherapy (FX), head scraping (GS), and combined therapy (CK+FX+GS). Symptom reduction was assessed using standardized instruments (MIDAS, HADS, VAS, PSQI), with statistical modeling of clinical outcomes based on mean differences and standard deviation (SD) metrics across groups. The results reveal that the combination therapy group demonstrated significantly lower mean pain intensity (VAS: 0.57 ± 0.75 vs. CK 3.14 ± 0.92, p < 0.01) and psychological well-being (HADS-A: 5.14 ± 1.23 vs. CK 10.71 ± 2.64), PSQI of different groups after treatment are decreased and Grade IV prevalence declined by 73% (p < 0.001), significantly lowering risks of extreme functional impairment. 58% of Grade III patients transitioned to Grade II/I, highlighting broad applicability for moderate disability cohorts in the MIDAS scores. Comparative analysis of SD values further indicated greater consistency in treatment responses within the combination group, suggesting enhanced reliability of the integrated protocol. These results, grounded in descriptive statistical modeling, provide robust evidence for optimizing non-pharmacological migraine management in aging populations while aligning with healthy aging objectives through TCM- Western integrative strategies.
© The Authors, published by EDP Sciences, 2025
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.